Akcea Therapeutics: 2Q Earnings Snapshot
BOSTON (AP) _ Akcea Therapeutics Inc. (AKCA) on Tuesday reported a loss of $37.3 million in its second quarter.
On a per-share basis, the Boston-based company said it had a loss of 40 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.
The biopharmaceutical company posted revenue of $26.6 million in the period.
Akcea Therapeutics shares have fallen 32% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $20.46, a decline of 40% in the last 12 months.